Canada - Healthcare, Regulatory and Reimbursement Landscape

The publisher, the industry analysis specialist, has released its latest report: “Canada - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Canada. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The growth in Canada's pharmaceutical market is attributed to the adoption of R&D activities towards advanced therapies and increased partnerships among pharmaceutical companies and academia, small and medium-sized enterprises (SMEs), government, and research centers. In 2020, the Canadian pharmaceutical market was the ninth largest globally in terms of value. Canada’s pharmaceutical market, based on production value, $23.86 billion in 2013 increased to $25.55 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 0.98%. It is forecast to reach about $27.08 billion in 2026. In 2016, the medical devices market in Canada was worth $8.02 billion, which increased at a CAGR of 6.09% to $10.79 billion in 2021. It is expected to grow at a CAGR of 3.96% from 2022 to reach $12.96 billion in 2027.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
Profiles and SWOT analyses of the major players in the pharmaceutical market: Johnson & Johnson, Novartis, Abbvie, Ceapro, and Thera technologies.
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Boston Scientific, Bausch Health, and AlphaProTech.
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities for and challenges to growth in the Canadian healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Canadian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Canadian healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the Canadian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Canada
2.4 Key Events: Canadian Healthcare Timeline, 2015-2021
2.5 Key Events: Canadian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Top Completed Deals by Value, 2020-2021
2.8 Country Profile, Canada, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Canada
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Market Segment, Generics, Canada
3.7 Pharmaceutical Market - Market Segment, Biologics and Biosimilars, Canada
3.8 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Canada
3.9 Major Therapeutic Areas, Canada
3.10 COVID-19 Epidemiology, Canada
3.11 COVID-19 Impact and Developments in the Healthcare Market, Canada
3.12 Covid-19 Clinical Trials Landscape, Canada
3.13 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Canada, 2020-2021
6.2 Deal Analysis: Medical Device Market, Canada, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Canada
7.2 HealthTech Deals Landscape, Canada
7.3 Key HealthTech Deals, Canada
7.4 Adoption of Technology in Healthcare, Canada
7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Canada
7.6 HealthTech Landscape: Benefits and Risks, Canada

8. Market Access

8.1 Overview of Healthcare System, Canada
8.2 Reimbursement of Pharmaceutical Products, Canada
8.3 Reimbursement of Medical Devices, Canada
8.4 Overview of Insurance Providers, Public Insurance, Canada
8.5 Overview of Insurance Providers, Private Insurance, Canada
8.6 Healthcare Spending and Prescription Drug Price Trend, Canada
8.7 Pricing Policies, Canada
8.8 Regulatory Landscape, Canada
8.8.1 Marketing Authorization for Pharmaceutical Products, Canada
8.8.2 Marketing Authorization for Medical Devices, Canada
8.8.3 Intellectual Property Rights, Patent, Canada
8.8.4 Intellectual Property Rights, Trademark, Canada
8.8.5 Clinical Trial Regulation Process, Canada
8.8.6 Pharmaceutical Clinical Trials Landscape, Canada
8.8.7 Medical Devices Clinical Trials Landscape, Canada
8.8.8 Pharmaceutical Export and Import, Canada
8.8.9 Pharmaceutical Advertising Regulations, Canada
8.8.10 Pharmacy Regulations, Canada
8.8.11 Labeling and Packaging Regulations, Canada

9. Country Healthcare Landscape

9.1 Canadian Healthcare Policy Highlights
9.2 Healthcare Facilities, Canada
9.3 Healthcare Parameters, Canada
9.4 Life Expectancy and Immunization Rate, Canada
9.5 Environmental Health, Canada
9.6 Healthcare Personnel, Canada
9.7 Disease Burden, Canada
9.8 Healthcare Expenditure, Canada

10 Trade Associations, Canada11 Trade Fairs, Canada12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: Approved Biosimilars, Canada 2020-2021
Table 2: Major Therapeutic Areas by Production Value ($B), Canada, 2020
Table 3: COVID-19 Indicators (Number of Cases), Global and Canada, 2020-2021
Table 4: COVID-19-Related Travel Restrictions, Canada, 2020-2021
Table 5: Authorized COVID-19 Vaccines, Canada, 2020-2021
Table 6: List of Authorized Treatments for COVID-19, Canada, 2020-2021
Table 7: Total COVID-19 Vaccine Distribution Canada, 2021
Table 8: COVID-19 IVD Products (December ‘20- December ‘21), Canada, 2020-2021
Table 9: Medical Device Market, Canada, Major Segments ($B), 2021
Table 10: Orthopedic Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: General Surgery Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Hospital Supplies Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 13: Cardiovascular Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 14: Diabetes Care Devices Market, Canada, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 15: AI/ML Medical Devices Approved by Health Canada, Canada, 2020-2021
Table 16: List of Provincial Insurance Programs, Canada, 2021
Table 17: TPF, Pricing Tiers, Canada, 2021
Table 18: Fees for Examination of Drug Submission, Canada, 2021
Table 19: Fees for Right to Sell Drugs, Canada, 2021
Table 20: Classification and Regulation Regarding Medical Devices, Canada, 2021
Table 21: Fees for Examination of Medical Devices License Application, Canada, 2021
Table 22: Fees for Right to Sell Medical Devices, Canada, 2021
Table 23: Patent Fees, Canada, 2021
Table 24: Trademark Fees, Canada, 2021
Table 25: Importation Requirements for Health Products in Canada
Table 26: Trade Fairs, Canada

List of Figures

Figure 1: Pharmaceutical Market, Canada, Revenue ($B and CADB), 2013-2020
Figure 2: Medical Devices Market, Canada, Revenue ($B), 2016-2021
Figure 3: Healthcare Startups in Canada, 2021
Figure 4: Country Profile, Canada, 2020
Figure 5: Pharmaceutical Market, Canada, Revenue ($B and CADB), 2013-2020
Figure 6: Pharmaceutical Market, Canada, Revenue Forecast ($B and CADB), 2021-2026
Figure 7: Pharmaceutical Exports ($B), Canada, 2013-2020
Figure 8: Top Export Partners, Canada, 2020
Figure 9: Pharmaceutical Imports ($B), Canada, 2013-2020
Figure 10: Top Import Partners, Canada, 2020
Figure 11: Pharmaceutical Market, Supply Channel, Canada, 2021
Figure 12: Generic Share by Value (%), Canada, 2013-2020
Figure 13: Generic Share by Volume (%), Canada, 2013-2020
Figure 14: OTC Medicines Market, Major Distribution Channels ($B), Canada, 2020
Figure 15: OTC Medicines Market, Revenue ($B), Canada, 2013-2020
Figure 16: OTC Medicines Market, Major Categories ($M), Canada, 2020
Figure 17: Major Therapeutic Areas by Production Value, Canada, 2020
Figure 18: COVID-19 Cases, Canada, 2020-2021
Figure 19: COVID-19 Deaths, Canada, 2020-2021
Figure 20: COVID-19 Fiscal Stimulus Timeline, Canada, 2020-2021
Figure 21: COVID-19 Vaccine Doses Administration, Number of Vaccine Doses Administered, Canada, 2021
Figure 22: COVID-19 Clinical Trials Count by Market Categories, Canada, 2020-2021
Figure 23: COVID-19 Clinical Trials Count by Trial Status, Canada, 2020-2021
Figure 24: Top COVID-19 Clinical Trials Sponsors by Trial Count, Canada, 2020-2021
Figure 25: Medical Devices Market, Canada, Revenue ($B), 2016-2021
Figure 26: Medical Devices Market, Canada, Revenue Forecast ($B), 2022-2027
Figure 27: Medical Device Market, Canada, Major Segments (%), 2021
Figure 28: Orthopedic Devices Market, Canada, Revenue ($B), 2017-2025
Figure 29: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2020
Figure 30: General Surgery Market, Canada, Revenue ($B), 2017-2025
Figure 31: General Surgery Market, Canada, Market Share of Major Players (%), 2020
Figure 32: Hospital Supplies Market, Canada, Revenue ($B), 2017-2025
Figure 33: Hospital Supplies Market, Canada, Market Share of Major Players (%), 2020
Figure 34: Cardiovascular Devices Market, Canada, Revenue ($B), 2017-2025
Figure 35: Cardiovascular Devices Market, Canada, Market Share of Major Players (%), 2020
Figure 36: Diabetes Care Devices Market, Canada, Revenue ($B), 2017-2025
Figure 37: Diabetes Care Devices Market, Canada, Market Share of Major Players (%), 2020
Figure 38: Diagnostics Market, Canada, Revenue ($B), 2015-2020
Figure 39: Diagnostics Market, Canada, Revenue Forecast ($B), 2021-2025
Figure 40: Medical Devices Market, Revenue ($B) of Major Companies, Canada, 2020
Figure 41: Deal Value and Deal Count, Pharmaceutical Market, Canada, 2020-2021
Figure 42: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Canada, 2020-2021
Figure 43: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Canada, 2020-2021
Figure 44: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Canada, 2020-2021
Figure 45: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Canada, 2020-2021
Figure 46: M&A Deals by Quarter, Pharmaceutical Market, Canada, 2020-2021 (by Value and by Number)
Figure 47: VC Deals by Quarter, Pharmaceutical Market, Canada, 2020-2021 (by Value and by Number)
Figure 48: Deal Value and Deal Count, Medical Devices Market, Canada, 2020-2021
Figure 49: Deal Value and Deal Count Sub-types, Medical Devices Market, Canada, 2020-2021
Figure 50: Deal Value and Deal Count, Quarterly, Medical Devices Market, Canada, 2020-2021
Figure 51: Top Equipment Areas by Deal Value ($B), Medical Devices Market, Canada, 2020-2021
Figure 52: Top Equipment Areas by Deal Count, Medical Devices Market, Canada, 2020-2021
Figure 53: M&A Deals by Quarter, Medical Devices Market, Canada, 2020-2021 (by Value and by Number)
Figure 54: VC Deals by Quarter, Medical Devices Market, Canada, 2020-2021 (by Value and by Number)
Figure 55: Key Areas of Focus, Digital Technology Supercluster, Canada, 2020
Figure 56: Top Digital Innovations, Canada, 2021
Figure 57: Objectives of Pan-Canadian AI Strategy, 2017
Figure 58: Deal Value ($M), HealthTech, Canada, 2020-2021
Figure 59: Deal Count (No. of Deals), HealthTech, Canada, 2020-2021
Figure 60: Adoption of Technology in Healthcare, Canada
Figure 61: Principles of Digital Charter Implementation Act, Canada, 2020
Figure 62: Organization of the Health System, Canada, 2020
Figure 63: Canadian Health Databases Managed by CIHI, Canada, 2021
Figure 64: Common Drug Review Process, Canada, 2020
Figure 65: Pan-Canadian Oncology Drug Review Process, Canada, 2020
Figure 66: INESSS Evaluation Process For Registration, Canada, 2020
Figure 67: Drug Reimbursement Process, Canada, 2020
Figure 68: Medical Devices Reimbursement Process, Canada, 2020
Figure 69: Private Insurance Coverage, Canada, 2013-2020
Figure 70: OOP Expenditure (% of Total Expenditure on Health), Canada, 2013-2020
Figure 71: Annual Rate of Change (%), Consumer Price Index, Healthcare Products (Base Year 2002=100), Canada, 2013-2020
Figure 72: HPFB Organizational Structure, Canada, 2019
Figure 73: CTD Format, Canada, 2020
Figure 74: New Drug Approval Process, Canada, 2020
Figure 75: New Medical Device Approval Process, Canada, 2021
Figure 76: Patent Registration Process, Canada, 2021
Figure 77: Trademark Registration Process, Canada, 2021
Figure 78: Clinical Trial Regulation Process, Canada, 2021
Figure 79: Pharmaceutical Clinical Trials Count by Trial Status, Canada, 2020-2021
Figure 80: Pharmaceutical Clinical Trials Count by Therapy Areas, Canada, 2020-2021
Figure 81: Pharmaceutical Clinical Trials Count by Phase, Canada, 2020-2021
Figure 82: Top Five Pharmaceutical Clinical Trial Sponsors by Count, Canada, 2020-2021
Figure 83: Medical Devices Clinical Trials Count by Trial Status, Canada, 2020-2021
Figure 84: Medical Devices Clinical Trials Count by Indication, Canada, 2020-2021
Figure 85: Medical Devices Clinical Trials Count by Category, Canada, 2020-2021
Figure 86: Top Five Medical Devices Clinical Trial Sponsors by Count, Canada, 2020-2021
Figure 87: PAAB Approval Process, Canada, 2021
Figure 88: Digital Health Canada Strategy 2023

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1971EUR$1,995USD£1,641GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€2956EUR$2,992USD£2,461GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3942EUR$3,990USD£3,281GBP

Scope

Reasons to Buy

Table of Contents

Related Topics

Related Reports

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Healthcare BPO Market Report by Payer Service, Provider Service, Pharmaceutical Service, and Region 2024-2032

Healthcare Reimbursement Global Market Report 2024

Offsite Medical Case Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Care Management Solutions Global Market Report 2024